Cleared Traditional

K201454 - DSG Connect Technology (FDA 510(k) Clearance)

Class II Neurology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K201454 · Spineguard S.A. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2021
Decision
254d
Days
Class 2
Risk

K201454 is an FDA 510(k) clearance for the DSG Connect Technology. Classified as Neurosurgical Nerve Locator (product code PDQ), Class II - Special Controls.

Submitted by Spineguard S.A. (Vincennes, FR). The FDA issued a Cleared decision on February 10, 2021 after a review of 254 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 874.1820 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Spineguard S.A. devices

Submission Details

510(k) Number K201454 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 01, 2020
Decision Date February 10, 2021
Days to Decision 254 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
106d slower than avg
Panel avg: 148d · This submission: 254d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code PDQ Neurosurgical Nerve Locator
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 874.1820
Definition To Locate Or Monitor Function Of Spinal Nerve Roots Or Peripheral Nerves During Neurosurgery.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Consultant

Hogan Lovells US LLP
John Smith

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - PDQ Neurosurgical Nerve Locator

All 34
Devices cleared under the same product code (PDQ) and FDA review panel - the closest regulatory comparables to K201454.
Sterile Insulated Dilators, 5, 10, 16mm (MDT-0442S)
K253580 · Tedan Surgical Innovations · Apr 2026
Neuralytix iD3 System (NTX-9001)
K243636 · Neuralytix, LLC · Jun 2025
TELIGEN System Peripheral Motor Nerve Stimulation Indications
K223438 · Medos International SARL · Feb 2023
ATEC IOM Accessory Instruments
K221821 · Alphatec Spine, Inc. · Sep 2022
PediGuard Threaded
K220160 · Spineguard S.A. · Mar 2022
Neurosign V4 Intraoperative Nerve Monitor
K203684 · Magstim Company, Ltd. · Mar 2021